Complete financial analysis of Winner Medical Co., Ltd. (300888.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Winner Medical Co., Ltd., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- Country Garden Holdings Company Limited (CTRYY) Income Statement Analysis – Financial Results
- Ekarat Engineering Public Company Limited (AKR.BK) Income Statement Analysis – Financial Results
- HCL Technologies Limited (HCLTECH.BO) Income Statement Analysis – Financial Results
- Pieridae Energy Limited (PTOAF) Income Statement Analysis – Financial Results
- Zimmer Biomet Holdings, Inc. (ZBH.SW) Income Statement Analysis – Financial Results
Winner Medical Co., Ltd. (300888.SZ)
About Winner Medical Co., Ltd.
Winner Medical Co., Ltd. engages in the research and development, manufacture, and marketing of cotton-based medical dressings and medical disposables, and consumer products in China. It operates through, Medical Consumables and Healthy Consumer Goods segments. The company offers wound care products, including gauze sheets, non-woven sheets, gauze bandage, dressing change kits, silicone dressings, alginate dressings, etc.; infection prevention products, such as surgical packs, surgical gowns, masks, protective clothing, isolation gowns, gloves, footwear, hats, etc.; and disinfection and cleaning products comprising cotton swabs, cotton pads, cotton balls, alcohol cotton pads, disinfectant, etc. It also offers non-woven fabric; non-woven consumer goods, such as cotton tissues, wet wipes, sanitary pads, cotton swabs, makeup cotton pads, disposable underwear, etc.; and textile consumer goods, including baby supplies and clothing, adult clothing, and other textile consumer goods. The company provides its products under the winner, Purcotton, and PureH2B brands through pharmacy chain store, hospital, e-commerce, and supermarket distribution channels. The company also sells its products to approximately 110 countries worldwide. Winner Medical Co., Ltd. was founded in 1991 and is based in Shenzhen, China. Winner Medical Co., Ltd. is a subsidiary of Winner Group Limited.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8.19B | 11.35B | 8.04B | 12.53B | 4.57B | 3.84B | 3.50B | 2.56B | 1.82B | 1.51B | 1.27B |
| Cost of Revenue | 4.39B | 5.97B | 4.03B | 5.07B | 2.21B | 1.95B | 1.83B | 1.31B | 1.05B | 990.33M | 887.71M |
| Gross Profit | 3.79B | 5.38B | 4.01B | 7.46B | 2.36B | 1.89B | 1.67B | 1.25B | 766.46M | 519.54M | 384.26M |
| Gross Profit Ratio | 46.33% | 47.38% | 49.88% | 59.55% | 51.65% | 49.16% | 47.77% | 48.71% | 42.13% | 34.41% | 30.21% |
| Research & Development | 322.05M | 487.58M | 298.16M | 411.38M | 155.19M | 116.56M | 88.63M | 61.08M | 52.79M | 48.25M | 0.00 |
| General & Administrative | 304.79M | 126.08M | 70.93M | 112.74M | -131.25M | -105.73M | -66.90M | 141.27M | 175.94M | 143.05M | 125.73M |
| Selling & Marketing | 2.09B | 2.05B | 1.99B | 1.58B | 1.36B | 1.04B | 838.10M | 512.46M | 305.36M | 187.06M | 131.27M |
| SG&A | 2.38B | 2.18B | 2.06B | 1.69B | 1.22B | 935.56M | 771.21M | 653.73M | 481.31M | 330.11M | 257.00M |
| Other Expenses | 274.31M | 521.25M | 346.50M | 370.51M | 345.77M | -3.10M | 31.07M | 10.23M | 18.03M | 13.14M | 7.11M |
| Operating Expenses | 2.97B | 3.19B | 2.70B | 2.47B | 1.73B | 1.35B | 1.11B | 743.13M | 495.92M | 342.49M | 265.65M |
| Cost & Expenses | 7.37B | 9.16B | 6.73B | 7.54B | 3.94B | 3.31B | 2.93B | 2.06B | 1.55B | 1.33B | 1.15B |
| Interest Income | 133.91M | 123.91M | 137.98M | 26.15M | 9.07M | 4.60M | 3.67M | 0.00 | 0.00 | 0.00 | -0.68 |
| Interest Expense | 64.43M | 50.04M | 29.99M | 3.61M | 24.90M | 30.56M | 23.62M | 1.85M | 0.00 | 873.72K | 20.28M |
| Depreciation & Amortization | 595.03M | 555.15M | 432.37M | 257.74M | 155.11M | 68.44M | 54.50M | 39.50M | 58.79M | 55.56M | 26.29M |
| EBITDA | 1.41B | 2.52B | 1.92B | 4.76B | 806.19M | 586.36M | 583.56M | 531.78M | 310.06M | 206.94M | 122.14M |
| EBITDA Ratio | 17.20% | 25.32% | 24.40% | 39.41% | 16.70% | 16.67% | 18.29% | 20.10% | 17.04% | 13.71% | 9.60% |
| Operating Income | 817.97M | 1.98B | 1.48B | 4.53B | 641.77M | 495.71M | 516.12M | 492.06M | 251.27M | 151.38M | 95.85M |
| Operating Income Ratio | 9.99% | 17.41% | 18.36% | 36.16% | 14.03% | 12.91% | 14.76% | 19.22% | 13.81% | 10.03% | 7.54% |
| Total Other Income/Expenses | -68.12M | -57.04M | -12.88M | -29.28M | -3.36M | 3.57M | 185.96K | 10.23M | 12.76M | 4.18M | 5.14M |
| Income Before Tax | 749.85M | 1.92B | 1.46B | 4.50B | 638.41M | 500.47M | 517.19M | 502.29M | 264.03M | 155.57M | 100.99M |
| Income Before Tax Ratio | 9.16% | 16.91% | 18.20% | 35.92% | 13.96% | 13.04% | 14.79% | 19.62% | 14.51% | 10.30% | 7.94% |
| Income Tax Expense | 121.30M | 245.30M | 225.32M | 679.91M | 91.21M | 74.99M | 89.38M | 91.82M | 42.66M | 25.83M | 12.18M |
| Net Income | 580.40M | 1.65B | 1.24B | 3.81B | 546.29M | 424.68M | 427.20M | 409.64M | 220.54M | 129.06M | 88.14M |
| Net Income Ratio | 7.09% | 14.54% | 15.42% | 30.40% | 11.94% | 11.06% | 12.21% | 16.00% | 12.12% | 8.55% | 6.93% |
| EPS | 0.99 | 2.81 | 2.08 | 6.38 | 0.91 | 0.81 | 0.83 | 0.79 | 0.43 | 0.35 | 0.24 |
| EPS Diluted | 0.99 | 2.81 | 2.08 | 6.38 | 0.91 | 0.81 | 0.83 | 0.79 | 0.43 | 0.35 | 0.24 |
| Weighted Avg Shares Out | 588.29M | 587.63M | 596.24M | 597.09M | 597.09M | 521.53M | 515.59M | 516.64M | 514.56M | 367.57M | 367.57M |
| Weighted Avg Shares Out (Dil) | 588.29M | 587.63M | 596.24M | 597.09M | 597.09M | 521.54M | 515.59M | 516.66M | 514.59M | 367.57M | 367.57M |
Source: https://incomestatements.info
Category: Stock Reports